Ophelia is a telepsychiatry platform for treating opioid use disorder (OUD). The company provides online therapy and medication-assisted treatment (MAT) to reduce opioid cravings and withdrawal symptoms. The company offers an alternative to traditional rehab for treating OUD and claims to be a less costly option in comparison to monthly visits to a doctor and the cost of medication, which can range between USD 800 and USD 900.
Ophelia’s monthly subscription, costing USD 195 per month out of pocket, covers MAT, care team support, and virtual clinician visits via audio and video calls. Members can speak to their physician on a weekly, bi-weekly, or monthly basis.
Key customers and partnerships
Ophelia has established partnerships with several major health insurers to expand access to its virtual OUD care. In March 2024, the company announced it was in-network for Highmark Wholecare's Medicaid and Dual Special Needs Plan members in Pennsylvania, covering 360,000 additional patients. This built on Ophelia's existing relationship with Highmark Health since 2021, which provided coverage for 2.9 million commercial members.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.